DIFFERENTIAL-EFFECTS OF SODIUM-BICARBONATE AND ALUMINUM HYDROXIDE ON THE ABSORPTION AND ACTIVITY OF GLIPIZIDE

被引:13
作者
KIVISTO, KT
NEUVONEN, PJ
机构
[1] Department of Pharmacology, University of Turku, Turku
关键词
GLIPIZIDE; GASTROINTESTINAL ABSORPTION; SODIUM BICARBONATE; ALUMINUM HYDROXIDE; GLUCOSE; DRUG INTERACTION; HEALTHY VOLUNTEERS;
D O I
10.1007/BF00265848
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide have been studied in healthy volunteers in two randomized cross-over trials. After an overnight fast, 5 mg glipizide was given either with 150 ml water or with water containing 3.0 g sodium bicarbonate or 1.0 g aluminium hydroxide. Sodium bicarbonate significantly increased the AUC of plasma glipizide from 0 to 0.5 h, 0 to 1 h, and from 0 to 2 h (six-, four- and twofold, respectively). The time to peak concentration (t(max)) fell from 2.5 h during the control phase to 1.0 h during the sodium bicarbonate phase. The absorption half-life (t1/2a), lag time and mean residence time (MRT) were also significantly decreased. No significant change in peak plasma concentration (C(max)), total AUC or elimination half-life (t1/2) was noted. The decremental plasma glucose areas from 0 to 1 h and 0 to 2 h were significantly larger (80% and 50%, respectively) than during the control phase. The maximal decrease in glucose was 50% greater during the sodium bicarbonate phase, and the time to reach it was reduced by 35 min. Aluminium hydroxide had no significant effects on the rate or extent of absorption of glipizide, and the glucose response also remained unaffected. It is concluded that the concomitant ingestion of sodium bicarbonate and glipizide may result in accelerated absorption of glipizide and an increased effect on glucose. A common dose of aluminium hydroxide did not appear to affect the absorption of glipizide.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 16 条
[1]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GLIPIZIDE IN HUMAN-PLASMA AND URINE [J].
EMILSSON, H .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 421 (02) :319-326
[2]   EFFECTS OF ANTACIDS ON THE CLINICAL PHARMACOKINETICS OF DRUGS - AN UPDATE [J].
GUGLER, R ;
ALLGAYER, H .
CLINICAL PHARMACOKINETICS, 1990, 18 (03) :210-219
[3]   INTERACTION OF ETHANOL AND GLIPIZIDE IN HUMANS [J].
HARTLING, SG ;
FABER, OK ;
WEGMANN, ML ;
WAHLINBOLL, E ;
MELANDER, A .
DIABETES CARE, 1987, 10 (06) :683-686
[4]  
HURWITZ A, 1974, AM REV RESPIR DIS, V109, P41
[5]   ANTACID THERAPY AND DRUG KINETICS [J].
HURWITZ, A .
CLINICAL PHARMACOKINETICS, 1977, 2 (04) :269-280
[6]   INTERINDIVIDUAL VARIATION IN THE ABSORPTION OF GLIBENCLAMIDE IN MAN [J].
IKEGAMI, H ;
SHIMA, K ;
TANAKA, A ;
TAHARA, Y ;
HIROTA, M ;
KUMAHARA, Y .
ACTA ENDOCRINOLOGICA, 1986, 111 (04) :528-532
[7]   GLIPIZIDE PHARMACOKINETICS - EFFECTS OF AGE, DIABETES, AND MULTIPLE DOSING [J].
KRADJAN, WA ;
KOBAYASHI, KA ;
BAUER, LA ;
HORN, JR ;
OPHEIM, KE ;
WOOD, FJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (12) :1121-1127
[8]   PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF ORAL HYPOGLYCEMIC AGENTS - AN UPDATE [J].
MARCHETTI, P ;
NAVALESI, R .
CLINICAL PHARMACOKINETICS, 1989, 16 (02) :100-128
[9]   SULFONYLUREA ANTIDIABETIC DRUGS - AN UPDATE OF THEIR CLINICAL-PHARMACOLOGY AND RATIONAL THERAPEUTIC USE [J].
MELANDER, A ;
BITZEN, PO ;
FABER, O ;
GROOP, L .
DRUGS, 1989, 37 (01) :58-72
[10]   EFFECT OF MAGNESIUM-HYDROXIDE ON THE ABSORPTION OF TOLFENAMIC AND MEFENAMIC ACIDS [J].
NEUVONEN, PJ ;
KIVISTO, KT .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (05) :495-501